Literature DB >> 23534794

Gene expression profiling of intrahepatic cholangiocarcinoma.

Ittisak Subrungruanga1, Charin Thawornkunob, Porntip Chawalitchewinkoon-Petmitrc, Chawalit Pairojkul, Sopit Wongkham, Songsak Petmitrb.   

Abstract

Intrahepatic cholangiocarcinoma (ICC) is ranked as one of the top five causes of cancer-related deaths. ICC in Thai patients is associated with infection with the liver fluke, Opisthorchis viverrini, but the molecular basis for development remains unclear. The present study employed a microarray approach to compare gene expression profiles of ICCs and normal liver tissues from the same patients residing in Northeast Thailand, a region with a high prevalence of liver fluke infection. In ICC samples, 2,821 and 1,361 genes were found to be significantly up- and down-regulated respectively (unpaired t-test, p<0.05; fold-change>2.0). For validation of the microarray results, 7 up-regulated genes (FXYD3, GPRC5A, CEACAM5, MUC13, EPCAM, TMC5, and EHF) and 3 down- regulated genes (CPS1, TAT, and ITIH1) were selected for confirmation using quantitative RT-PCR, resulting in 100% agreement. The metallothionine heavy metal pathway contains the highest percentage of genes with statistically significant changes in expression. This study provides exon-level expression profiles in ICC that should be fruitful in identifying novel genetic markers for classifying and possibly early diagnosis of this highly fatal type of cholangiocarcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 23534794

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  21 in total

Review 1.  Distinct functions of TMC channels: a comparative overview.

Authors:  Xiaomin Yue; Yi Sheng; Lijun Kang; Rui Xiao
Journal:  Cell Mol Life Sci       Date:  2019-10-04       Impact factor: 9.261

2.  Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.

Authors:  Ken Sasaki; Hiroshi Kurahara; Eric D Young; Shoji Natsugoe; Asami Ijichi; Tomoo Iwakuma; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2017-03-13       Impact factor: 5.150

3.  Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Somsak Likhitrattanapisal; Jaitip Tipanee; Tavan Janvilisri
Journal:  Tumour Biol       Date:  2016-07-22

4.  Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review.

Authors:  Gyem Tshering; Palden Wangyel Dorji; Wanna Chaijaroenkul; Kesara Na-Bangchang
Journal:  Am J Trop Med Hyg       Date:  2018-04-05       Impact factor: 2.345

5.  Role of laminin and cognate receptors in cholangiocarcinoma cell migration.

Authors:  Kittiya Islam; Parichut Thummarati; Pakkanun Kaewkong; Banchob Sripa; Tuangporn Suthiphongchai
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

Review 6.  The emerging roles of GPRC5A in diseases.

Authors:  Honglei Zhou; Isidore Rigoutsos
Journal:  Oncoscience       Date:  2014-11-25

Review 7.  An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.

Authors:  Pattaya Seeree; Phorutai Pearngam; Supeecha Kumkate; Tavan Janvilisri
Journal:  Int J Genomics       Date:  2015-09-02       Impact factor: 2.326

8.  Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.

Authors:  Tavan Janvilisri; Kawin Leelawat; Sittiruk Roytrakul; Atchara Paemanee; Rutaiwan Tohtong
Journal:  Dis Markers       Date:  2015-04-28       Impact factor: 3.434

9.  Ion channels expression and function are strongly modified in solid tumors and vascular malformations.

Authors:  Antonella Biasiotta; Daniela D'Arcangelo; Francesca Passarelli; Ezio Maria Nicodemi; Antonio Facchiano
Journal:  J Transl Med       Date:  2016-10-04       Impact factor: 5.531

10.  Expression and clinical significance of FXYD3 in endometrial cancer.

Authors:  Yifei Li; Xia Zhang; Shuwen Xu; Jing Ge; Jing Liu; Lin Li; Guiying Fang; Yali Meng; Hongzhen Zhang; Xiaofeng Sun
Journal:  Oncol Lett       Date:  2014-05-23       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.